WO2017188908A1 - Intravenously implanted metal alloy stent and a new method for the production of this stent - Google Patents

Intravenously implanted metal alloy stent and a new method for the production of this stent Download PDF

Info

Publication number
WO2017188908A1
WO2017188908A1 PCT/TR2017/050159 TR2017050159W WO2017188908A1 WO 2017188908 A1 WO2017188908 A1 WO 2017188908A1 TR 2017050159 W TR2017050159 W TR 2017050159W WO 2017188908 A1 WO2017188908 A1 WO 2017188908A1
Authority
WO
WIPO (PCT)
Prior art keywords
production
stent
alloy
tray
laser
Prior art date
Application number
PCT/TR2017/050159
Other languages
French (fr)
Inventor
Fehim FINDIK
Cuma Bindal
Ramazan AKDEMIR
Osman IYIBILGIN
Mahmut OZACAR
Azim GOKCE
Original Assignee
Findik Fehim
Cuma Bindal
Akdemir Ramazan
Iyibilgin Osman
Ozacar Mahmut
Gokce Azim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Findik Fehim, Cuma Bindal, Akdemir Ramazan, Iyibilgin Osman, Ozacar Mahmut, Gokce Azim filed Critical Findik Fehim
Publication of WO2017188908A1 publication Critical patent/WO2017188908A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148Materials at least partially resorbable by the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/02Inorganic materials
    • A61L31/022Metals or alloys
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B22CASTING; POWDER METALLURGY
    • B22FWORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
    • B22F10/00Additive manufacturing of workpieces or articles from metallic powder
    • B22F10/20Direct sintering or melting
    • B22F10/28Powder bed fusion, e.g. selective laser melting [SLM] or electron beam melting [EBM]
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B22CASTING; POWDER METALLURGY
    • B22FWORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
    • B22F10/00Additive manufacturing of workpieces or articles from metallic powder
    • B22F10/30Process control
    • B22F10/32Process control of the atmosphere, e.g. composition or pressure in a building chamber
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B22CASTING; POWDER METALLURGY
    • B22FWORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
    • B22F10/00Additive manufacturing of workpieces or articles from metallic powder
    • B22F10/30Process control
    • B22F10/36Process control of energy beam parameters
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B22CASTING; POWDER METALLURGY
    • B22FWORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
    • B22F12/00Apparatus or devices specially adapted for additive manufacturing; Auxiliary means for additive manufacturing; Combinations of additive manufacturing apparatus or devices with other processing apparatus or devices
    • B22F12/40Radiation means
    • B22F12/44Radiation means characterised by the configuration of the radiation means
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B33ADDITIVE MANUFACTURING TECHNOLOGY
    • B33YADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y10/00Processes of additive manufacturing
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B33ADDITIVE MANUFACTURING TECHNOLOGY
    • B33YADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y80/00Products made by additive manufacturing
    • CCHEMISTRY; METALLURGY
    • C22METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22CALLOYS
    • C22C33/00Making ferrous alloys
    • C22C33/02Making ferrous alloys by powder metallurgy
    • C22C33/0257Making ferrous alloys by powder metallurgy characterised by the range of the alloying elements
    • C22C33/0278Making ferrous alloys by powder metallurgy characterised by the range of the alloying elements with at least one alloying element having a minimum content above 5%
    • CCHEMISTRY; METALLURGY
    • C22METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22CALLOYS
    • C22C38/00Ferrous alloys, e.g. steel alloys
    • C22C38/002Ferrous alloys, e.g. steel alloys containing In, Mg, or other elements not provided for in one single group C22C38/001 - C22C38/60
    • CCHEMISTRY; METALLURGY
    • C22METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22CALLOYS
    • C22C38/00Ferrous alloys, e.g. steel alloys
    • C22C38/02Ferrous alloys, e.g. steel alloys containing silicon
    • CCHEMISTRY; METALLURGY
    • C22METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22CALLOYS
    • C22C38/00Ferrous alloys, e.g. steel alloys
    • C22C38/04Ferrous alloys, e.g. steel alloys containing manganese
    • CCHEMISTRY; METALLURGY
    • C22METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22CALLOYS
    • C22C38/00Ferrous alloys, e.g. steel alloys
    • C22C38/10Ferrous alloys, e.g. steel alloys containing cobalt
    • CCHEMISTRY; METALLURGY
    • C22METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22CALLOYS
    • C22C38/00Ferrous alloys, e.g. steel alloys
    • C22C38/12Ferrous alloys, e.g. steel alloys containing tungsten, tantalum, molybdenum, vanadium, or niobium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/16Materials with shape-memory or superelastic properties
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P10/00Technologies related to metal processing
    • Y02P10/25Process efficiency

Definitions

  • a bio-degradable and shape memory material is used within the scope of the invention. Similar materials are also used in prior art.
  • EP2398521 available in current art.
  • This stent is formed by a composition that is composed of Fe, Mn, Si and C. This material does not have shape memory feature. It can only be used in balloon expansion method.
  • a stent made of an iron based allot is mentioned in Chinese Patent document No. CN103974728 available in current art.
  • Such alloy contains Fe-X-Y.
  • X is at least one austenite balancing element selected from the group that is composed of Co, Ni, Mn, Cu, Re, Rh, Ru, Ir, Pt.
  • Y is at least one corrosion activator selected from the group that is composed of Pd and Au.
  • production of bio-degradable (soluble in body) metal stents with 3D printer technology by using shape memory alloys, which are types of smart materials does not involve.
  • the stent developed for achieving such purposes contain Fe-Mn-X-Y alloy.
  • X contains at least one element selected from the group that is composed of S, Co and Mo.
  • Y contains at least one element selected from the group that is composed of C and Pd. Production is performed with 3D printer.
  • the laser power required for combining this alloy by means of melting method is determined. Laser power varies depending on the composition of the stent material and alloy ratios.
  • Mean powder size 5 micron to 20 micron (weighted average -15 micron)
  • Laser power 200-400 W

Abstract

The invention is related to a permeable, tubular metal alloy stent, which is placed intravenously and ensures continuity of flow inside the vessel at necessary rate by being expended by a certain extent just after the placement, wherein Fe-Mn-X-Y alloy is used for producing biodegradable stents, X contains at least one elements selected from the group that is composed of Si, Co, Mo and Y contains at least one elements selected from the group that is composed of C and Pd., in such alloy Fe is characterized as 47-75%, Mn is 20-35%, Si is 1-6%, Co is 1-4%, Mo is 1-4%, C is 1-2% and Pd is 1-2% by weight. The invention is a method of production of a permeable, tubular metal alloy stent, which is placed intravenously and ensures continuity of flow inside the vessel at necessary rate by being expended by a certain extent just after the placement, wherein - the production is performed with 3D printer, - a laser source with 200-400 W power is used during production, - powders forming the alloy are laid properly on a tray inside the production pool, - the laser source is located stationary at mid-top point of the tray and in a way that it is distant from the tray at focal length, - mirrors are used for ensuring directing laser beams into desired point, - process steps contain scanning of each layer by directing laser beams by means of mirrors during production and combining them in a manner that desired geometry is achieved mean powder size is 5-20 microns, laser power is 200-400 W, scanning rate is 10 m/s - 20 m/s, diameter of laser beam is between 80 µm – 150 µm and layer height is between 20 µm – 200 µm during the production and argon or nitrogen gas is used as a protective atmosphere during production.

Description

Intravenously Implanted Metal Alloy Stent and
A New Method For the Production of This Stent
Field Of The Invention
This invention is related to stents used for expanding narrowed vessels in body.
Background Of The Invention
Medical devices, which are commonly used for expanding narrowed vessels in the body, are called stent. Stents are permeable, tubular structures, which are placed intravenously and ensure continuity of flow inside the vessel at necessary rate by being expended by a certain extent just after the placement. Stents can either be made of metal or plastic.
Stents can be classified depending on different characteristics. Generally; stents are classified as bare metal stents, drug eluted stents, soluble stents by structure; cylindrical, grill, circular, multiple design and special type stents by design and carotid, coronary, renal and peripheral stents by the area of application. Stents are classified under two groups as self-expandable stents, balloon expandable stents depending on the application systems.
Among the stent types, stents that can be soluble in body, have become more important in recent years. Studies in this field are in progress both in our country and around the world. Plastic stents that can be soluble in body are commercialized and started to be applied on humans.
Production methods used for stent production in current art involve techniques that contain complex and multiple operations and production takes longer. Furthermore, it is difficult and sometimes impossible to make custom fabrication with these methods. In addition to that, production time and cost of the stent is high. If production with 3D method is used for producing metal stents that can be soluble in body, it will be possible to solve aforesaid problems as well as to produce both commonly used and standardized stents and custom stents which are not standard and used in limited numbers, rapidly and economically.
Stents that are used currently are the ones that are made of corrosion resistant metals and stay in the body permanently. Bare metal stents are generally made of 316L stainless steel, nitinol and cobalt-chrome alloy. Thanks to stent application, re contraction of the vessel after the angiography is reduced with structural effect of the metal stent. On the other hand some disadvantages of fixed metallic implants limit their widespread use. These limitations include low thrombogenecity, continuous physical pain, chronic inflammatory local reactions, mechanical behavioural disharmony between vessel with and without stent, growth adaptation failure in young patients and unavailability to further surgical vascular operations or problems caused during the application.
Since fundamental effect of stent implantation is ensured by structural effect of the stent, 6 to 12 months are needed for reshaping and recovery of the vessel. After that period, presence of stent inside the body does not have any benefit. Metal stents inhibit restenosis but they stay in the body for an unnecessarily long period after they perform their functions. Permanent presence of stent inside the body causes problems such as long term endothelial dysfunction, delayed re-endotalization, thrombogenecity, permanent physical irritation and chronic inflammatory local reactions.
A bio-degradable and shape memory material is used within the scope of the invention. Similar materials are also used in prior art.
A bioerodable stent is mentioned in European Patent document No.
EP2398521 available in current art. This stent is formed by a composition that is composed of Fe, Mn, Si and C. This material does not have shape memory feature. It can only be used in balloon expansion method.
A stent made of an iron based allot is mentioned in Chinese Patent document No. CN103974728 available in current art. Such alloy contains Fe-X-Y. X is at least one austenite balancing element selected from the group that is composed of Co, Ni, Mn, Cu, Re, Rh, Ru, Ir, Pt. Y is at least one corrosion activator selected from the group that is composed of Pd and Au. In known applications of the art, production of bio-degradable (soluble in body) metal stents with 3D printer technology by using shape memory alloys, which are types of smart materials, does not involve.
Objective of Invention
Purpose of the invention is to develop a bio-degradable (soluble in body) metal stents by using shape memory alloys, which are types of smart materials.
The stent developed for achieving such purposes contain Fe-Mn-X-Y alloy. Wherein, X contains at least one element selected from the group that is composed of S, Co and Mo. Wherein, Y contains at least one element selected from the group that is composed of C and Pd. Production is performed with 3D printer. Detailed Explanation of the Invention
Stents that are planned to be produced within the scope of the invention are under balloon expandable stents.
Metal stents that can be soluble inside the body, dissolve during blood flow and removed with blood. The stent integrates with the vessel short time after its implantation and settles inside the vascular tissue. The stent, after performing its function for the first 6 months, will be absorbed by the vascular tissue and cover mineral need of the body. It does not have any harmful effect for the body but it is very important in covering minerals (iron, manganese etc.) needed by the body during the dissolution.
Thanks to the invention, aforesaid problems will be resolved substantially and additional benefits will be obtained. There is no existing study related to metallic stent production with 3D printer method. Material to be used in production is produced with mechanical alloying. Changing the alloy will change all parameters related to production with 3D printer. Changing the laser power will affect production speed. As the laser power increases, production time decreases. Furthermore sintering temperature varies depending on the material (alloy) to be used in production. No complete melting occurs during production with 3D printer. Achieving melting that will allow integration of materials will be sufficient. On the other hand, parameters such as progress rate, laser focus diameter and layer thickness are determined and used depending on the material used.
Material to be used in production is a material that is in shape memory materials class and can be soluble (by absorbing inside tissue) inside the body. Defining production parameters of this material for a 3D printer is a very important innovation. Thus, this bio-degradable material can be used in areas such as implant production.
There are studies on using shape memory materials in stent production but there are no applications on metal sent production with 3D printer method. If this material is used in stent production; the stent will be absorbed inside the body and removed after completing its function or it will be possible for the body to cover its mineral needs from the stent. Depending on the period of completion of the function of the stent or implant inside the body, period for the dissolution and corrosion of the stent can be adjusted or changed. In vivo dissolution periods of the product will be determined by means of corrosion tests to be performed. It will be possible to delay or move this dissolution period to an earlier time by means of new additives to be added.
Restenosis can be reduced or prevented thanks to mechanical features of the stent manufactured. Restenosis is one of the most commonly encountered problems in existing stents.
The material offered is a bio-degradable and shape memory material. As the result of the investigations made, similar material ingredients have been encountered. However use of production with 3D printer method in stent production is an innovation. Therefore, it will be possible to perform custom made stent production in very short time. Production in desired diameter, geometry and size depending on the condition of the vessel and occlusion will be able to be performed.
Thanks to the invention, post application problems caused by permanent stents are eliminated. In addition to that, it will be possible to test stents that are new and have different geometries in a very short time and try them on practice models or human body.
In current art, stent production technique involves highly complex and tough processes. On the other hand, it is possible to produce stents fast, economically and custom made with 3D printer method.
Implants that can be soluble in body can be produced by fully defining use of the alloy developed in 3D printer. Thus; inconveniencies arising from prolonged existence of implants completing their functions in the body are eliminated and complications that may arise during the operations made for removing the implant can be avoided. Stent production in traditional method is performed by sensitive casting of the alloy in desired combination in tubular form and laser processing following it. Another method used in production of shape memory alloys is the power metallurgy (PM) method. PM method has advantages over other production methods such as high raw material-product return, low energy consumption, suitability for mass production, fine grain size and high mechanical characteristics. PM method's "net-shape" feature, which allows obtaining final product with a shorter process (with less process steps) is another factor that is considered while choosing this method.
The biggest cost item in Powder Metallurgy (PM) method is composed of the moulding expenses. Both in traditional PM method (Press-Sinter) and power injection method, there is a need for a different mould for every product. Mould cost is eliminated by application of articulating production methods to metal powders and it becomes possible to produce complex shaped parts which are difficult or not possible to be produced.
In the literature, there are studies on producing Fe-Mn based bio- degradable alloys with PM method. Hermawan et al. alloyed elemental Fe and Mn powders and sintered them either under argon or reductive Ar+H2 atmosphere at temperature of 1200 C as a part of their study. They performed cold rolling in order to increase density and obtained characteristics close to 316 L stainless steel. Furthermore, the biodegradation speed they obtain is higher than pure iron. Same researchers performed mechanical alloying of elemental Fe and Mn powders in a way that creates Fe-XMn (X=20,25,30,35) alloy and obtained highest resistance in Fe-20 Mn and Fe-25 Mn alloys and highest ductility in Fe-30 Mn and Fe-35 Mn alloys after sintering. They reported that all alloys formed had higher corrosion rates than pure iron and indicated that Fe-30 Mn and Fe-35 Mn alloy was the most suitable alloy for a stent. In another study (Harjanto 2012), Fe- 25Mn-lC and Fe-35Mn-lC alloys created with PM method were examined and it was indicated that pores emerging as the result of PM process would have a positive impact on biodegradation rate. In the only study (Chotu et al.,2013) on producing Fe-Mn based biodegradable materials with a 3D printer by using alloy powders other than production with traditional PM method, Fe-30Mn alloy was used and the technology used was based on spraying the material called 3D Inkjet Printing. In the method subject to the invention on the other hand, apart from this method, sintering-melting of biodegradable and shape memory metal alloys are planned.
Purpose of the Invention is to develop a method of production for bio- degradable (soluble in body) metal stents with 3D printer technology by using shape memory alloys, which are types of smart materials, which are very hard to produce with traditional methods.
Fe-Mn-X-Y (X=Si, Co, Mo), (Y= C, Pd) (Fe 47-75, Mn = %20-35, Si = %l-6, Co = %l-4, Mo = %l-4, C = %l-2, Pd = 1-2% by weight) smart alloys have been developed for producing biodegradable stents. Optimum Mn and Si values have been determined for the production of a stent with the most suitable physical and mechanical characteristics. Using of optimum values, which will maximize X and Y values, poses great importance. Specificity of alloys in this composition is that they are biodegradable and have shape memory feature. The likes of alloys developed were produced with traditional methods and it was seen that alloys with limited number of combinations were studied in the literature.
After determining the layer heights for alloy powders with sizes varying between 5 to 20 microns, the laser power required for combining this alloy by means of melting method is determined. Laser power varies depending on the composition of the stent material and alloy ratios.
A laser source with 200-400 W power is used during production. Then, powders forming the alloy are laid properly on a tray inside the production pool.
Laying of the material as a smooth layer affects measurement accuracy and surface quality. The laser source is located stationary at mid-top point of the tray and in a way that it is distant from the tray at focal length. Mirrors are used for ensuring directing laser beams into desired point. Process steps contain scanning of each layer by directing laser beams by means of mirrors during production and combining them in a manner that desired geometry is achieved. Determination of the melting temperature and focal length regarding to the alloy constitutes great importance. Melting temperature is determined as the result of the tests to be applied on the alloy. Impact created by the laser on the material may vary depending on the focal height, diameter of the laser beam and layer thickness. If these values are not optimum, resistance of the material decreases and a suitable combination cannot be performed.
Technical specifications of the 3D printer are as follows:
Mean powder size: 5 micron to 20 micron (weighted average -15 micron) Laser power: 200-400 W
Scan rate: 10 m/s - 20 m/s (scan rate varies depending on the laser power and layer thickness used.)
Laser beam diameter: 80 μηι - 150 μηι
Layer height: 20 μηι - 200 μιη The invention is related to a permeable, tubular metal alloy stent, which is placed intravenously and ensures continuity of flow inside the vessel at necessary rate by being expended by a certain extent just after the placement, wherein Fe- Mn-X-Y alloy is used for producing biodegradable stents, X contains at least one elements selected from the group that is composed of Si, Co, Mo and Y contains at least one elements selected from the group that is composed of C and Pd., in such alloy Fe is characterized as 47-75%, Mn is 20-35%, Si is 1-6%, Co is 1-4%, Mo is 1-4%, C is 1-2% and Pd is 1-2% by weight.
The invention is a method of production of a permeable, tubular metal alloy stent, which is placed intravenously and ensures continuity of flow inside the vessel at necessary rate by being expended by a certain extent just after the placement, wherein the production is performed with 3D printer,
a laser source with 200-400 W power is used during production, powders forming the alloy are laid properly on a tray inside the production pool,
- the laser source is located stationary at mid-top point of the tray and in a way that it is distant from the tray at focal length,
mirrors are used for ensuring directing laser beams into desired point, process steps contain scanning of each layer by directing laser beams by means of mirrors during production and combining them in a manner that desired geometry is achieved. mean powder size is 5-20 microns, laser power is 200-400 W, scanning rate is 10 m/s - 20 m/s, diameter of laser beam is between 80 μηι - 150 μιη and layer height is between 20 μιτι - 200 μιτι during the production and argon or nitrogen gas is used as a protective atmosphere during production.

Claims

C L A I M S
A permeable, tubular metal alloy stent, which is placed intravenously and ensures continuity of flow inside the vessel at necessary rate by being expended by a certain extent just after the placement characterised in that; Fe-Mn-X-Y alloy is used for producing biodegradable stents, X contains at least one elements selected from the group that is composed of Si, Co, Mo and Y contains at least one elements selected from the group that is composed of C and Pd.
An alloy mentioned in Claim 1 characterised in that; Fe is 47-75%, Mn is 20-35%, Si is 1-6%, Co is 1-4%, Mo is 1-4%, C is 1-2% and Pd is 1-2% by weight.
A method of production of a permeable, tubular metal alloy stent, which is placed intravenously and ensures continuity of flow inside the vessel at necessary rate by being expended by a certain extent just after the placement characterised in that;
the production is performed with 3D printer,
a laser source with 200-400 W power is used during production, powders forming the alloy are laid properly on a tray inside the production pool,
the laser source is located stationary at mid-top point of the tray and in a way that it is distant from the tray at focal length,
mirrors are used for ensuring directing laser beams into desired point, process steps contain scanning of each layer by directing laser beams by means of mirrors during production and combining them in a manner that desired geometry is achieved. A stent production method mentioned in claim 3 characterised in that; mean powder size is 5-20 microns, laser power is 200-400 W, scanning rate is 10 m/s - 20 m/s, diameter of laser beam is between 80 μηι - 150 μηι and layer height is between 20 μπι - 200 μηι during the production.
A stent production method mentioned in claim 3 characterised in that; argon or nitrogen gas is used as a protective atmosphere during production.
PCT/TR2017/050159 2016-04-25 2017-04-24 Intravenously implanted metal alloy stent and a new method for the production of this stent WO2017188908A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2016/05339A TR201605339A2 (en) 2016-04-25 2016-04-25 Metal Alloy Stent Placed In The Vein And A New Method For The Production Of This Stent
TR2016/05339 2016-04-25

Publications (1)

Publication Number Publication Date
WO2017188908A1 true WO2017188908A1 (en) 2017-11-02

Family

ID=59295285

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2017/050159 WO2017188908A1 (en) 2016-04-25 2017-04-24 Intravenously implanted metal alloy stent and a new method for the production of this stent

Country Status (2)

Country Link
TR (1) TR201605339A2 (en)
WO (1) WO2017188908A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000003611A1 (en) 2020-02-21 2021-08-21 Getters Spa Bioabsorbable pseudoelastic Fe-Mn-X-Y alloys for medical implants
IT202000007717A1 (en) 2020-04-10 2021-10-10 Getters Spa Bioabsorbable Fe-Mn-Si-X alloys for medical implants
WO2022187904A1 (en) * 2021-03-11 2022-09-15 Newsouth Innovations Pty Limited Shape memory alloy

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100174367A1 (en) * 2009-01-08 2010-07-08 Bio Dg, Inc Implantable medical devices comprising bio-degradable alloys
US20100217370A1 (en) * 2009-02-20 2010-08-26 Boston Scientific Scimed, Inc. Bioerodible Endoprosthesis
US20130103161A1 (en) * 2011-10-20 2013-04-25 Medtronic Vascular, Inc. Iron Based Alloys for Bioabsorbable Stent
US20150010422A1 (en) * 2013-07-03 2015-01-08 Medtronic Vascular, Inc. Methods of Manufacturing a Drug-Eluting Stent
US9114032B1 (en) * 2014-05-21 2015-08-25 Medtronic Vascular, Inc. Method of making a stent

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100174367A1 (en) * 2009-01-08 2010-07-08 Bio Dg, Inc Implantable medical devices comprising bio-degradable alloys
US20100217370A1 (en) * 2009-02-20 2010-08-26 Boston Scientific Scimed, Inc. Bioerodible Endoprosthesis
EP2398521A2 (en) 2009-02-20 2011-12-28 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis
US20130103161A1 (en) * 2011-10-20 2013-04-25 Medtronic Vascular, Inc. Iron Based Alloys for Bioabsorbable Stent
CN103974728A (en) 2011-10-20 2014-08-06 美敦力瓦斯科尔勒公司 Iron based alloys for bioabsorbable stent
US20150010422A1 (en) * 2013-07-03 2015-01-08 Medtronic Vascular, Inc. Methods of Manufacturing a Drug-Eluting Stent
US9114032B1 (en) * 2014-05-21 2015-08-25 Medtronic Vascular, Inc. Method of making a stent

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DA-TREN CHOU ET AL: "Novel processing of iron-manganese alloy-based biomaterials by inkjet 3-D printing", ACTA BIOMATERIALIA, vol. 9, no. 10, 1 November 2013 (2013-11-01), AMSTERDAM, NL, pages 8593 - 8603, XP055411037, ISSN: 1742-7061, DOI: 10.1016/j.actbio.2013.04.016 *
HERMAWAN H ET AL: "Fe-Mn alloys for metallic biodegradable stents: Degradation and cell viability studies", ACTA BIOMATERIALIA, ELSEVIER, AMSTERDAM, NL, vol. 6, no. 5, 1 May 2010 (2010-05-01), pages 1852 - 1860, XP027039408, ISSN: 1742-7061, [retrieved on 20091123] *
XU ZHIGANG ET AL: "A comparative study of powder metallurgical (PM) and wrought Fe-Mn-S", MATERIALS SCIENCE AND ENGINEERING: A, vol. 630, 10 April 2015 (2015-04-10), pages 116 - 124, XP029146581, ISSN: 0921-5093, DOI: 10.1016/J.MSEA.2015.02.021 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000003611A1 (en) 2020-02-21 2021-08-21 Getters Spa Bioabsorbable pseudoelastic Fe-Mn-X-Y alloys for medical implants
WO2021165333A1 (en) 2020-02-21 2021-08-26 Saes Getters S.P.A. Bioresorbable pseudoelastic fe-mn-x-y alloys for medical implants
IT202000007717A1 (en) 2020-04-10 2021-10-10 Getters Spa Bioabsorbable Fe-Mn-Si-X alloys for medical implants
WO2021204811A1 (en) 2020-04-10 2021-10-14 Saes Getters S.P.A. Bioresorbable fe-mn-si-x alloys for medical implants
WO2022187904A1 (en) * 2021-03-11 2022-09-15 Newsouth Innovations Pty Limited Shape memory alloy

Also Published As

Publication number Publication date
TR201605339A2 (en) 2017-02-21

Similar Documents

Publication Publication Date Title
Murr et al. Next generation orthopaedic implants by additive manufacturing using electron beam melting
US7641983B2 (en) Medical devices including composites
US8382824B2 (en) Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides
Niinomi Recent metallic materials for biomedical applications
JP4995420B2 (en) High strength vacuum deposited Nitinol alloy film, medical thin film graft material, and method of making same.
Venezuela et al. Addressing the slow corrosion rate of biodegradable Fe-Mn: Current approaches and future trends
US8500787B2 (en) Radiopaque markers and medical devices comprising binary alloys of titanium
EP1977722B1 (en) Bioabsorbable composite stents
AU2003303710B2 (en) Medical devices
Korei et al. A review on design characteristics and fabrication methods of metallic cardiovascular stents
US20080160259A1 (en) Medical devices and methods of making the same
Carluccio et al. The influence of laser processing parameters on the densification and surface morphology of pure Fe and Fe-35Mn scaffolds produced by selective laser melting
US20060122687A1 (en) Amorphous alloy stents
US8500786B2 (en) Radiopaque markers comprising binary alloys of titanium
US20080091267A1 (en) Medical devices including hardened alloys
WO2017188908A1 (en) Intravenously implanted metal alloy stent and a new method for the production of this stent
EP1487515B1 (en) Mri and x-ray compatible stent material
US20160263288A1 (en) Bioerodible Magnesium Alloy Microstructures for Endoprostheses
Li et al. Additive manufacturing of vascular stents
de Freitas et al. Sintering behaviour of Co-28% Cr-6% Mo compacted blocks for dental prosthesis
Langi et al. Characterisation of additively manufactured metallic stents
Schuessler et al. Manufacturing of stents: optimize the stent with new manufacturing technologies
US20230390090A1 (en) Nitinol stents and methods of fabrication thereof
Mondal et al. Low cost porous Ti-6Al-4 V structures by additive manufacturing for orthopaedic applications
WO2023075691A2 (en) Methods of fabricating stents and stents thereof

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17736784

Country of ref document: EP

Kind code of ref document: A1

122 Ep: pct application non-entry in european phase

Ref document number: 17736784

Country of ref document: EP

Kind code of ref document: A1